Logo image of AKBA

AKEBIA THERAPEUTICS INC (AKBA) Stock Analyst Earnings Estimates

NASDAQ:AKBA - Nasdaq - US00972D1054 - Common Stock - Currency: USD

3.72  -0.04 (-1.06%)

After market: 3.72 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
AKBA revenue by date.AKBA revenue by date.
292.5M
38.17%
194.623M
-33.46%
160.18M
-17.70%
204.95M
27.95%
294.88M
43.88%
313.83M
6.43%
402.53M
28.26%
494.65M
22.89%
617.75M
24.89%
745.52M
20.68%
868.47M
16.49%
EBITDA
YoY % growth
AKBA ebitda by date.AKBA ebitda by date.
2.99M
101.41%
-6.848M
-329.03%
-8.71M
-27.19%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
AKBA ebit by date.AKBA ebit by date.
-34.7M
86.09%
-44.475M
-28.17%
-46.214M
-3.91%
-8.89M
80.76%
47.884M
638.61%
56.781M
18.58%
137.36M
141.91%
244.47M
77.98%
364.18M
48.97%
471.62M
29.50%
572.29M
21.35%
Operating Margin
AKBA operating margin by date.AKBA operating margin by date.
-11.86%-22.85%-28.85%-4.34%16.24%18.09%34.12%49.42%58.95%63.26%65.90%
EPS
YoY % growth
AKBA eps by date.AKBA eps by date.
-0.44
74.12%
-0.28
36.36%
-0.33
-17.86%
-0.07
80.22%
0.08
218.75%
0.12
57.89%
0.39
220.83%
0.53
35.06%
0.72
36.54%
0.89
22.54%
1.06
19.54%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26
EPS
Q2Q % growth
-0.02
55.38%
-0.03
67.36%
-0.04
61.24%
-0.01
-117.00%
Revenue
Q2Q % growth
48.549M
11.23%
47.57M
27.10%
50.191M
7.94%
61.873M
7.91%
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
2.715M
133.01%
-1.491M
86.69%
-486.54K
96.11%
5.243M
-61.77%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
0.03
133.33%
-0.050.08165.36%
Q4 2024
Q2Q % growth
-0.10 -0.08-0.02-22.55%
Q3 2024
Q2Q % growth
-0.10
-25.00%
-0.06-0.04-54.81%
Q2 2024
Q2Q % growth
-0.04
33.33%
-0.050.0126.47%
Q1 2024
Q2Q % growth
-0.09
35.71%
-0.08-0.01-15.08%
Q4 2023
Q2Q % growth
0.00
100.00%
-0.040.04100.00%
Q3 2023
Q2Q % growth
-0.08
71.43%
-0.090.017.73%
Q2 2023
Q2Q % growth
-0.06
-126.09%
-0.03-0.03-135.29%
Q1 2023
Q2Q % growth
-0.14
60.00%
-0.150.018.50%
Q4 2022
Q2Q % growth
-0.04
90.00%
-0.190.1578.99%
Q3 2022
Q2Q % growth
-0.28
17.65%
-0.15-0.13-83.01%
Q2 2022
Q2Q % growth
0.23
145.10%
-0.320.55171.76%
Q1 2022
Q2Q % growth
-0.35
22.22%
-0.29-0.06-19.01%
Q4 2021
Q2Q % growth
-0.40
33.33%
-0.34-0.06-19.35%
Q3 2021
Q2Q % growth
-0.34
19.05%
-0.32-0.02-5.26%
Q2 2021
Q2Q % growth
-0.51
-15.91%
-0.32-0.19-58.10%
Q1 2021
Q2Q % growth
-0.45
4.26%
-0.30-0.15-50.19%
Q4 2020
Q2Q % growth
-0.60
24.05%
-0.41-0.19-46.53%
Q3 2020
Q2Q % growth
-0.42
8.70%
-0.18-0.24-138.70%
Q2 2020
Q2Q % growth
-0.44
10.20%
-0.510.0713.29%
Q1 2020
Q2Q % growth
-0.47
24.19%
-0.630.1625.53%
Q4 2019
Q2Q % growth
-0.79 -0.48-0.31-63.92%
Q3 2019
Q2Q % growth
-0.46 -0.43-0.03-5.94%
Q2 2019
Q2Q % growth
-0.49 -0.33-0.16-49.54%
Q1 2019
Q2Q % growth
-0.62 -0.41-0.21-51.82%
AKBA Yearly EPS VS EstimatesAKBA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 -2 -4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
57.336M
75.84%
45.78M11.556M25.24%
Q4 2024
Q2Q % growth
46.497M
-17.26%
38.096M8.401M22.05%
Q3 2024
Q2Q % growth
37.428M
-10.98%
45.397M-7.969M-17.55%
Q2 2024
Q2Q % growth
43.648M
-22.58%
50.439M-6.791M-13.46%
Q1 2024
Q2Q % growth
32.607M
-18.74%
47.008M-14.401M-30.64%
Q4 2023
Q2Q % growth
56.196M
1.99%
56.501M-305K-0.54%
Q3 2023
Q2Q % growth
42.046M
-13.66%
49.147M-7.101M-14.45%
Q2 2023
Q2Q % growth
56.376M
-55.40%
60.282M-3.906M-6.48%
Q1 2023
Q2Q % growth
40.127M
-34.86%
47.618M-7.491M-15.73%
Q4 2022
Q2Q % growth
55.1M
-4.51%
48.347M6.753M13.97%
Q3 2022
Q2Q % growth
48.7M
-0.20%
48.111M589K1.22%
Q2 2022
Q2Q % growth
126.4M
138.94%
50.725M75.675M149.19%
Q1 2022
Q2Q % growth
61.6M
17.78%
45.108M16.492M36.56%
Q4 2021
Q2Q % growth
57.7M
3.04%
51.819M5.881M11.35%
Q3 2021
Q2Q % growth
48.8M
-18.67%
50.663M-1.863M-3.68%
Q2 2021
Q2Q % growth
52.9M
-41.29%
53.925M-1.025M-1.90%
Q1 2021
Q2Q % growth
52.3M
-40.90%
56.832M-4.532M-7.97%
Q4 2020
Q2Q % growth
56M
-19.54%
52.181M3.819M7.32%
Q3 2020
Q2Q % growth
60M
-34.78%
86.594M-26.594M-30.71%
Q2 2020
Q2Q % growth
90.1M
-10.62%
75.668M14.432M19.07%
Q1 2020
Q2Q % growth
88.5M
21.73%
79.031M9.469M11.98%
Q4 2019
Q2Q % growth
69.6M 95.01M-25.41M-26.74%
Q3 2019
Q2Q % growth
92M 101.37M-9.37M-9.24%
Q2 2019
Q2Q % growth
100.8M 92.949M7.851M8.45%
Q1 2019
Q2Q % growth
72.7M 82.636M-9.936M-12.02%
AKBA Yearly Revenue VS EstimatesAKBA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 63.16% 0% 66.75%
Revenue-0.08% 6.66% 0.85% 4.45%